ABSTRACT. The Sleeping Beauty (SB) transposon system is a promising new method for establishing persistent transgene expression in vivo. We applied the SB system for enhancing transgenesis in Saanen dairy goat fibroblast cells. We constructed a pKT2/CMV-EGFP-IRES-PURO vector and investigated the influence of transposon and transposase vector ratios on transfection efficiency in the Saanen goat fibroblast cells. To enhance the SB system performance, we developed a new transfection technique (double-transfection method) for the SB system. The cultured cells were transfected with transposase and transposon vectors successively, with a 42-h interval. Consequently, the transposase and DNA donor (transposon vector) can interact, both at the highest level. method, this new double-transfection method approximately doubled integration efficiency.
INTRODUCTION
Significant effort has been expended to virus-based gene delivery systems . Viral-vector vehicles, including retroviruses (Gordon and Anderson, 1994) , adenovirus , herpes simplex virus (Latchman, 1994) , lentivirus (Naldini, 1998) , and adeno-associated virus (Rabinowitz and Samulski, 1998) , can dramatically improve the frequency of integration events compared to non-viral vector vehicles. Many attempts have been made to explore a non-viral naked DNA-mediated gene delivery strategy using transposon systems for the expression of new genes in cells and tissues (Dupuy et al., 2002) . The Sleeping Beauty (SB) transposon system has been extensively used in animals for transgenesis and has resulted in stable integration and long-term expression of transgenes (Dupuy et al., 2001; Zhu et al., 2010) . SB transposon-based transfection consists of a transposase and a transposon. It is active in animal cells, human cultured cells (Ivics et al., 1997) , mouse somatic tissues (Yant et al., 2000) , and a mouse germ line (Fischer et al., 2001; Horie et al., 2001) . It mediates gene transfer that results in precise integration into a TA dinucleotide (Davidson et al., 2009) . Transposon integrants mostly express transgenes contained within the vector, unlike proviral integrants that are silenced when passed through the germ line (Jaenisch et al., 1976) . Saanen dairy goat is a milking breed and commonly called the poor man's cow (Padeh et al., 1971; Chen et al., 2005) . Saanen is among the major candidates for developing bioreactor because of the high level of protein in its milk. Keeping in mind the importance of Saanen dairy goats, this is the first time that the SB system was applied in Saanen dairy goat fibroblasts. We constructed a pKT2/CMV-GFP-IRES-PURO vector and established primary cultures of Saanen fibroblasts. The cultured cells were transfected with transposase and transposon vectors using the traditional and the newly developed method (twice-transfection method).
MATERIAL AND METHODS

Construct preparation
The CMV promoter and EGFP encoding sequence were amplified from the pEGFP-C1 vector (Clontech). The primers, sense: 5'-GGAAGATCTCCGCCATGCATTAGTTATTA-3' and antisense: 5'-ACATGCATGCTTACTTGTACAGCTCGTCCATG-3', were designed with the enzyme sites BglII (5'-end) and SphI (3'-end). The amplified fragment was inserted in the pKT2/TRE-Tight-BI-GH vector at upstream of EMCV IRES, using the BglII and SphI restriction sites, and the new plasmid was called pKT2/CMV-GFP-IRES-PURO.
Primary culture of Saanen fibroblasts
Skin biopsies were excised from the ear of a high generic merit 1-month-old Saanen.
The tissue biopsy was finely cut into small pieces (3-4 mm 2 ) aseptically in phosphatebuffered saline (PBS, GIBCO). The small pieces of tissue explants were cultured in T-75 flasks containing D-MEM (GIBCO) supplemented with 10% fetal bovine serum (FBS) and antibiotics at 37°C in a humidified incubator with 5% CO 2 and 95% air. After 7-8 days, fibroblasts appeared attached to the bottom of the flasks, forming a monolayer. When cell confluence was 90%, the explants were removed and the cells were transferred to new flasks. They were cryopreserved in a -80°C freezer before the experiment was performed.
Determining the optimum molar ratio
Cells at approximately 50% confluence were treated with medium containing various concentrations of puromycin (0, 1, 2, 3, 4, 5 μg/mL). The selective media were replenished every 3 days, and the appropriate concentration of puromycin was verified every four days. To obtain the optimum molar ratio for transfection of pKT2/CMV-GFP-IRES-PURO to pCMV-SB-Ultra, the pCMV-SB-Ultra and pKT2/CMV-GFP-IRES-PURO mixture was prepared with different molar ratios (0:1, 1:100, 1:10, 1:1) according to the concentration and molecular weight of vectors.
One day before transfection, fibroblasts were seeded at a density of 5-10 x 10 5 per well on 6-well culture plates and cells were 50-70% confluent at transfection time. First, confluent cells were transduced with different molar ratios of pCMV-SB-Ultra and pKT2/ CMV-GFP-IRES-PURO using lipofectamine 2000, according to the Invitrogen protocol. The medium containing transfection complexes was removed 6 h later and on the second day after transfection, cells were grown in medium supplemented with 2 μg/mL puromycin. The medium was replaced every 3 days and cells were grown before non-transgenic cells were killed.
Twice-transfection method
Confluent fibroblast cells (70-90%) were prepared on 6-well culture plates containing 1.5 mL D-MEM (GIBCO), 10% FBS. These cells were randomly divided into three groups.
In group 1, cells were tranduced with 4 μg plasmid mixture of pKT2/CMV-GFP-IRES-PURO to pCMV-SB-Ultra (10:1) and after 6 h the medium with tranfection complexes was removed. Two days after transfection, the cells were grown in medium supplemented with 2 μg/mL puromycin.
In group 2, cells were transduced with 2 μg pCMV-SB-Ultra, and after 6 h the medium with tranfection complexes was removed and a fresh medium was added. The cells were then transduced with pKT2/CMV-GFP-IRES-PURO 42 h later. Two days after the second transfection, the cells were grown in medium supplemented with 2 μg/mL puromycin.
In group 3, cells were first transduced with 2 μg pCMV-SB-Ultra and then 42 h later with 4 μg plasmid mixture of pKT2/CMV-GFP-IRES-PURO and pCMV-SB-Ultra (10:1). Two days after the second transfection, cells were grown in medium supplemented with 2 μg/mL puromycin.
In all groups, the medium was replaced every 3 days and cells were grown until nontransgenic cells were killed.
Karyotype analysis
Karyotype analysis of EGFP transgenic fibroblasts was performed with the DAPI Karyotyping kit (GENMED), according to the manufacturer protocol.
Statistical analysis
The total molecular weight of the DNA molecules pKT2/CMV-GFP-IRES-PURO and pCMV-SB-Ultra was calculated by the MB Advanced DNA Analysis software. Differences were analyzed statistically by one-way ANOVA using the SPSS software, and P < 0.05 was considered to be statistically significant.
RESULTS
pKT2/CMV-EGFP-IRES-PURO vector
The pKT2/CMV-EGFP-IRES-PURO vector was successfully constructed. The construction map of the newly constructed plasmid pKT2/CMV-EGFP-IRES-PURO is given in Figure 1 . Figure 1A provides information about the vector backbone from pKT2/TET-ON-GH, showing that the size of the vector backbone is 6549 bp. Figure 1B displays the agarose gel electrophoresis of pKT2/TET-ON-GH and (CMV/EGFP) digested with BglII and SphI enzymes, revealing the vector backbone (4668 and 1881 bp), and CMV/EGFP fragment (1348 bp), compared to a 500-bp ladder marker (Takara). Figure 1C shows the construction map of the pKT2/CMV-EGFP-IRES-PURO vector with a size of 6021 bp. Figure 1D shows the digestion result for the pKT2/CMV-EGFP-IRES-PURO vector with NheI and BamHI restriction enzymatic sites, yielding 4442-and 1579-bp fragments, respectively.
The optimum molar ratio for the SB system
The application of the MB Advanced DNA Analysis software for determining the total molecular weight of DNA molecules of pKT2/CMV-GFP-IRES-PURO and pCMV-SB-Ultra resulted in 3650659 and 2873616 g/mol, respectively. Figure 2A and B shows the molecular weight of DNA molecules of pKT2/CMV-GFP-IRES-PURO and pCMV-SB-Ultra.
Using UV microscopy, GFP was clearly detected in the primary goat cells transfected with the transposase vector and transposon vector but not in cells transfected with only transposon vector. The level of GFP expression was highest in Panel (1:10) compared to (0:1), (1:100) and (1:1) (Figure 3) .
The optimal molar ratio of the transposase vector and transposon vector was around 1:10 (Figure 4 ). The molar ratio had a profound effect on the detection of GFP in cells; a low (1:100) and high (1:1) molar ratio of transposase to transposon vector yielded fewer positive GFP cells.
Comparison between the traditional and the new method
The results for comparison between the traditional and the new transfection method are given in Figure 5 , which revealed that the newly developed method brought forth more GFP-positive cells. Figure 5 shows the comparison between the traditional and the new method.
Karyotyping
The karyotype results for GFP-positive cells by chromosomal DAPI-band analysis revealed that these cells had a normal karyotype after being subcultured for 6 passages. Figure  6 shows the chromosomal analysis. GFP-positive cells displayed no changes in chromosome number or morphology. This demonstrated that SB-mediated transfection by the twice-transfection method did not lead to chromosomal abnormalities. 
DISCUSSION
The construction of the pKT2/CMV-EGFP-IRES-PURO vector was successful with the insertion of a CMV promoter and EGFP into pKT2/TRE-Tight-BI-GH-rtTA-Advanced in place of the IRES fragment. pKT2/CMV-EGFP-IRES-PURO contains all features of the original vector, including the SB transposase-recognized sites IR/DR. The agarose gel result for size revealed that vector size was 6021 bp and that NheI and BamHI enzymes produced 4442-and 1579-bp fragments, respectively. The results for transfection with transposase and transposon vectors showed that the Sleeping Beauty system can be applied in goat fibroblasts. The expression of the vector remained at peak level after 12 to 72 h of transfection (Patterson and Lippincott-Schwartz, 2002) . We found that a 1:10 molar ratio of transposase to transposon vector was the best for integration efficiency in fibroblast cells, whereas with a 1:100 molar ratio, the transposase level is too low and affects the integration efficiency in fibroblast cells. It was also found that with a 1:1 molar ratio, although the amount of transposase vector is high, the mature proteins were not enough because most of the proteins in cells remain at a premature stage. In the traditional method, we found several conspicuous merits. It is also well known that the level of recombinant protein production is increased at 24-72 h after transfection (Thierry et al., 1997; Li et al., 2002) . When the expression level of the SB transposase protein is high, it becomes difficult to obtain a high level of plasmid DNA because of degradation by normal endosomal pathways (Cole et al., 1992) . The level of transposase will continuously decrease because of the competition between the expression of recombinant protein from transposon and transposase vectors. Lipofectamine 2000 capacity for carrying DNA into cells is limited (Thierry et al., 1997) , so a small amount of transposase plasmid can enter cells due to an appropriate proportion of transposase and transposon in the mixture. In view of the foregoing, we transduced the SB system into cells twice with a 42-h interval between the transposase and transposon vector transfections. The transposase and DNA donor (transposon vector) interact both at the topmost level, and the recombinant protein from transposon vector cannot be expressed when the transposase is highly active. As the transposase and transposon vectors were transfected separately in our newly developed method, there was a greater chance of their expression as mature rather than immature protein in cells. Thus, we were successful enough to show a higher level of pKT2/ CMV-EGFP-IRES-PURO integration efficiency using the Sleeping Beauty system in goat fibroblasts. We also found that after using our method (twice transfection method), no change was seen in the chromosome set up of cells (Figure 6 ). We conclude that in comparison with the traditional method, the twice transfection method increased the integration efficiency to a maximal level. Thus, this is the first successful attempt to apply the SB system by a new twice-transfection method in goat fibroblasts. Further study is needed to determine the optimal interval time and transfection reagents with lower cytotoxicity.
